Sandwell and West Birmingham Hospitals NHS Trust, West Bomwich, UK.
Centre of Gastroenterology Research, Queen Mary University London, London, UK.
Gut. 2019 Oct;68(10):1731-1750. doi: 10.1136/gutjnl-2018-318115. Epub 2019 Jul 31.
These guidelines on oesophageal manometry and gastro-oesophageal reflux monitoring supersede those produced in 2006. Since 2006 there have been significant technological advances, in particular, the development of high resolution manometry (HRM) and oesophageal impedance monitoring. The guidelines were developed by a guideline development group of patients and representatives of all the relevant professional groups using the Appraisal of Guidelines for Research and Evaluation (AGREE II) tool. A systematic literature search was performed and the GRADE (Grading of Recommendations Assessment, Development and Evaluation) tool was used to evaluate the quality of evidence and decide on the strength of the recommendations made. Key strong recommendations are made regarding the benefit of: (i) HRM over standard manometry in the investigation of dysphagia and, in particular, in characterising achalasia, (ii) adjunctive testing with larger volumes of water or solids during HRM, (iii) oesophageal manometry prior to antireflux surgery, (iv) pH/impedance monitoring in patients with reflux symptoms not responding to high dose proton pump inhibitors and (v) pH monitoring in all patients with reflux symptoms responsive to proton pump inhibitors in whom surgery is planned, but combined pH/impedance monitoring in those not responsive to proton pump inhibitors in whom surgery is planned. This work has been endorsed by the Clinical Services and Standards Committee of the British Society of Gastroenterology (BSG) under the auspices of the oesophageal section of the BSG.
这些食管测压和胃食管反流监测指南取代了 2006 年发布的指南。自 2006 年以来,技术有了重大进步,特别是高分辨率测压(HRM)和食管阻抗监测的发展。指南由患者和所有相关专业团体的代表组成的指南制定小组使用评估指南研究与评估(AGREE II)工具制定。进行了系统的文献检索,并使用 GRADE(推荐评估、制定与评价)工具评估证据质量,并决定建议的强度。关于以下方面的益处,做出了重要的强烈推荐:(i)在吞咽困难的研究中,HRM 优于标准测压,特别是在诊断贲门失弛缓症方面,(ii)在 HRM 期间进行更大体积的水或固体辅助测试,(iii)在进行抗反流手术前进行食管测压,(iv)对质子泵抑制剂高剂量治疗无效的反流症状患者进行 pH/阻抗监测,以及(v)对计划手术的质子泵抑制剂治疗有效的反流症状患者进行 pH 监测,但对计划手术的质子泵抑制剂治疗无效的患者进行 pH/阻抗联合监测。这项工作得到了英国胃肠病学会(BSG)临床服务和标准委员会的认可,并由 BSG 的食管科主持。